106 Chapter 5 Table S3. Point mutations associated with ciprofloxacin and rifampicin resistance and MICs. Isolate Outcome MIC ciprofloxacin Ciprofloxacinresistance associated mutations MIC rifampicin Rifampicinresistance associated mutations 37 Failure 2 S80F grlA ≤ 0.03 D471Y rpoB 507 Success ≤ 0.5 ≤ 0.03 690 Success ≤ 0.5 ≤ 0.03 720 Success 2 S80F grlA ≤ 0.03 1475 Success ≤ 0.5 ≤ 0.03 2213 Success ≤ 0.5 ≤ 0.03 2223 Success ≤ 0.5 ≤ 0.03 2285 Success ≤ 0.5 ≤ 0.03 2315 Success 1 ≤ 0.03 2392 Success ≤ 0.5 ≤ 0.03 2478 Success 1 ≤ 0.03 2654 Failure 2 S80F grlA ≤ 0.03 2673 Success ≤ 0.5 ≤ 0.03 2703 Success ≥ 8.0 S80F grlA S84L gyrA ≤ 0.03 2855 Success ≤ 0.5 ≤ 0.03 2866 Success 1 S80F grlA ≤ 0.03 2879 Success 2 S80F grlA ≤ 0.03 2905 Success 4 S80F grlA S84L gyrA ≤ 0.03 2970 Success ≤ 0.5 ≤ 0.03 2980 Success ≤ 0.5 ≤ 0.03 3025 Failure 2 S80F grlA ≤ 0.03 3260 Success ≤ 0.5 ≤ 0.03 3460 Success ≤ 0.5 ≤ 0.03 3464 Success ≤ 0.5 ≤ 0.03 3488 Success ≤ 0.5 ≤ 0.03 3839 Success ≥ 8.0 S84L gyrA S80Y grlA ≤ 0.03 4211 Success ≥ 8.0 S84L gyrA S80Y grlA ≤ 0.03 4998 Success ≤ 0.5 I45M grlA ≤ 0.03 5308 Success ≤ 0.5 ≤ 0.03 5606 Failure ≥ 8.0 S80F grlA S84L gyrA P585S grlB ≤ 0.03
RkJQdWJsaXNoZXIy MTk4NDMw